Origami Therapeutics, Inc.
Oral drugs to halt neurodegeneration
About Origami Therapeutics, Inc.
Where is Origami Therapeutics, Inc. headquartered?
Origami Therapeutics, Inc. is headquartered in San Diego, CA.
What does Origami Therapeutics, Inc. do?
Oral drugs to halt neurodegeneration
What problem does Origami Therapeutics, Inc. solve?
Neurodegenerative diseases (Alzheimer's, Huntington's, Parkinson's, ALS, and Frontotemporal Dementia) are driven by disease-causing proteins that current treatments don't adequately target.
What's Origami Therapeutics, Inc.'s solution?
Origami develops next-generation disease-modifying protein degraders and correctors using its ORICISION drug discovery platform to target and degrade disease-related proteins.
What makes Origami Therapeutics, Inc. different?
States its approach selectively and efficiently degrades disease-causing proteins while sparing normal forms of the protein, and uses small molecules for broad distribution in the body and ease of manufacture.
Related terms
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.
🏷 Embed this badge
Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.
